Patheon Announces Changes to its Commercial Operations Structure

TORONTO, May 21, 2013 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, announced today that Antonella Mancuso, President, Global Commercial Operations and Chief Manufacturing Officer, notified the company that she plans to resign from her positions with the company and its subsidiaries, effective July 10, 2013.

About Patheon Inc.

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms.  Through the company's recent acquisition of Banner Pharmacaps - a market leader in soft gelatin capsule technology - Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies.  The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe.  Patheon enables customer products to be launched with confidence anywhere in the world.  For more information visit www.patheon.com.

SOURCE Patheon Inc


SOURCE: Patheon Inc.

For further information:

Contact: 
Jennifer Almond
Senior Representative, Corporate Communications & Investor Relations
919 226 3200
investorrelations@patheon.com

Profil de l'entreprise

Patheon Inc.

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.